Bausch Health Companies Inc (BHC)
8.70
+0.10
(+1.16%)
USD |
NYSE |
Apr 19, 10:15
Bausch Health Revenue (TTM): 8.757B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.757B |
| September 30, 2023 | 8.542B |
| June 30, 2023 | 8.35B |
| March 31, 2023 | 8.15B |
| December 31, 2022 | 8.124B |
| September 30, 2022 | 8.127B |
| June 30, 2022 | 8.192B |
| March 31, 2022 | 8.325B |
| December 31, 2021 | 8.434B |
| September 30, 2021 | 8.451B |
| June 30, 2021 | 8.478B |
| March 31, 2021 | 8.042B |
| December 31, 2020 | 8.027B |
| September 30, 2020 | 8.038B |
| June 30, 2020 | 8.109B |
| March 31, 2020 | 8.597B |
| December 31, 2019 | 8.601B |
| September 30, 2019 | 8.498B |
| June 30, 2019 | 8.425B |
| March 31, 2019 | 8.401B |
| December 31, 2018 | 8.38B |
| September 30, 2018 | 8.422B |
| June 30, 2018 | 8.505B |
| March 31, 2018 | 8.61B |
| December 31, 2017 | 8.724B |
| Date | Value |
|---|---|
| September 30, 2017 | 8.964B |
| June 30, 2017 | 9.224B |
| March 31, 2017 | 9.411B |
| December 31, 2016 | 9.674B |
| September 30, 2016 | 10.03B |
| June 30, 2016 | 10.34B |
| March 31, 2016 | 10.65B |
| December 31, 2015 | 10.45B |
| September 30, 2015 | 9.912B |
| June 30, 2015 | 9.181B |
| March 31, 2015 | 8.490B |
| December 31, 2014 | 8.206B |
| September 30, 2014 | 8.047B |
| June 30, 2014 | 7.533B |
| March 31, 2014 | 6.587B |
| December 31, 2013 | 5.770B |
| September 30, 2013 | 4.626B |
| June 30, 2013 | 3.968B |
| March 31, 2013 | 3.693B |
| December 31, 2012 | 3.480B |
| September 30, 2012 | 3.249B |
| June 30, 2012 | 2.965B |
| March 31, 2012 | 2.755B |
| December 31, 2011 | 2.463B |
| September 30, 2011 | 2.290B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
8.027B
Minimum
Dec 2020
8.757B
Maximum
Dec 2023
8.330B
Average
8.35B
Median
Jun 2023
Revenue (TTM) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.386M |
| Xenon Pharmaceuticals Inc | -- |